Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
A possible role of the macronutrients and the basic elements of carbohydrates (glucose administration or depletion), proteins (amino acids such as tryptophan and tyrosine), and fat (unsaturated fatty acids) was recently proposed for age-related changes of cognitive function, and the cognitive decline of degenerative (AD) or vascular origin. The availability and utilization of glucose has been implicated in cognitive function not only as a result of nutritional and systemic metabolic conditions, but also, although speculatively, as a crucial phase of the mechanism of action of molecules used as cognitive-enhancers. Furthermore, many lines of evidence have focused on the importance of oxidative stress mechanisms and free radical damage in AD pathogenesis. In addition, epidemiological studies have recently reported an association between alcohol and the incidence of AD and predementia syndromes. Foods with large amounts of aluminium-containing additives or aluminium from drinking water may affect the risk of developing AD, aluminium more likely acting as a cofactor somewhere in the cascade of events leading to the demented brain. A role for other metals in dementia have been speculated, given the encouraging results reported from studies on peripheral zinc concentrations, zinc supplementation, serum copper, either bound with ceruloplasmin or not, and iron metabolism in AD. Nonetheless, more data are needed to support a possible role of these metals in dementing diseases. Healthy diets, antioxidant supplements, and the prevention of nutritional deficiencies or exposure to foods and water with high content of metals could be considered the first line of defence against the development and progression of cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
Seshadri, S., Beiser, A., Selhub, J., Jacques, P. F., Rosenberg, I. H., D'Agostino, R. B., Wilson, P. W. F., & Wolf, P. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011613 · Cited by 3,237 · cited 1×
“Therefore, an increased plasma homocysteine level seems to be a strong, independent risk factor for the development of dementia and AD, suggesting that the elevated homocysteine levels precede the onset of dementia, not resulting from dementia-relatednutritional and vitamin deficiencies [260].”
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 2×
“Interestingly, caffeine, another xanthine, is the most widely consumed behaviourally active substance in the Western countries [84].”
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380 · cited 1×
“The possibility of the therapeutic use of antioxidants and free radical scavengers (eg, vitamin E, Gingko Biloba extract EGb 761, melatonin, flavonoids, and carotenoids) to reduce the risk or slow the progression of the disease has been suggested [254].”
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 1×
“However, since rare mutations that occur in three genes: APP, presenilin1 (PSEN1), and presenilin2 (PSEN2) [106, 241,261] cause familial autosomal-dominant AD with early-onset (less than 5% of all AD cases) and all result in increased production of A β , it is clear that this pathway is important.”
Apolipoprotein E: Far More Than a Lipid Transport Protein
Mahley, R. W., & Rall, S. C. (2000) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.1.1.507 · Cited by 1,836
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447 · cited 1×
“There is also evidence indicating that zinc, copper, and iron are significantly elevated in the AD brain [10], and drugs with metal chelating properties could produce a significant reversal of A β plaque deposition in vitro and in vivo [37].”
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261 · cited 1×
“As seen above for cognitive decline, some have claimed there is a J or U shaped relation alsobetweenal-cohol drinking and dementia [129,159,210,251], while a recent study showed no U shaped relation for dementia, but the APOE genotype seemed to modify the relation, with risk of old age dementia…”
Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 2×
“In fact, in this study people who ate fish once or more weekly had a relative risk for AD of 0.4: the absolute risk reduction was about 9.5 percent [201].”
InfluentialEvidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide
Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114
Mediterranean diet and risk for Alzheimer's disease
Scarmeas, N., Stern, Y., Tang, M., Mayeux, R., & Luchsinger, J. A. (2006) · Annals of Neurology · doi:10.1002/ana.20854 · Cited by 1,103 · cited 1×
“Very recently, Scarmeas and colleagues reported the results of a community-based study involving 2,258 nondementedindividuals in New York, in which adherence to a traditional Mediterranean diet was associated with significantly reduction in risk for AD [258].”
Fish and Omega-3 Fatty Acid Intake and Risk of Coronary Heart Disease in Women
Hu, F. B. (2002) · JAMA · doi:10.1001/jama.287.14.1815 · Cited by 1,018 · cited 2×
“Scarmeas and colleagues used in this report a scale indicating the degree of adherence to the traditional Mediterranean diet originally constructed by Tri-chopoulou and colleagues [283] and revised to include fish intake [126].”
Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988 · cited 1×
“Further, a recent pilot phase II trial of clioquinol with double-blind placebo control has shown that the clio-quinol treatment arrested cognitive decline and lowered plasma A β 1-42 levels in AD subjects [238].”
Joseph, J. A., Shukitt-Hale, B., Denisova, N. A., Bielinski, D., Martin, A., McEwen, J. J., & Bickford, P. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-08114.1999 · Cited by 980 · cited 1×
“ing age-related cognitive decline [138].”
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895 · cited 3×
“Furthermore, a clear reduction of risk of cognitive decline has been found in a population sample with a high intake of polyunsaturated fatty acids (PU-FA) and monounsaturated fatty acids (MUFA) [140, 141,266,269–271].”
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease
Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748
Atrial Fibrillation and Dementia in a Population-Based Study: The Rotterdam Study
Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997) · Stroke · doi:10.1161/01.str.28.2.316 · Cited by 732 · cited 1×
“Apart from the association be-tween AD and vascular risk factors [221],such as arterial hypertension [262],diabetes mellitus [213],atrial fib-rillation [212], and generalized atherosclerosis [120], dietary patterns and preferences for different foods appear to be similar in patients with VaD and AD.”
Bush, A. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)00073-3 · Cited by 731 · cited 1×
“Regular consumption of antioxidants in the diet may have a beneficial effect in humans [30].”
Levy (1994) · doi:10.1017/s1041610294001626 · Cited by 706
Effects of Moderate Alcohol Consumption on the Central Nervous System*
Eckardt, M. J., File, S. E., Gessa, G. L., Grant, K. A., Guerri, C., Hoffman, P. L., Kalant, H., Koob, G. F., Li, T., & Tabakoff, B. (1998) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03695.x · Cited by 622 · cited 1×
“In general, alcohol impairs performance on psychomotor tracking, driving tasks, perception, sustained attention, and information processing [58,68,114].”
Rogers, J. T., Randall, J. D., Cahill, C. M., Eder, P. S., Huang, X., Gunshin, H., Leiter, L., McPhee, J., Sarang, S. S., Utsuki, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207435200 · Cited by 551 · cited 1×
“Further, as copper, iron has also been found to promote lipid peroxidation and cause damageto membrane proteins [281], and act as a transcriptional regulator of the A β PP [242].”
Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease
Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A. D., Hyman, B. T., Crain, B., Tang, M.-X., & Phelps, C. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802193380804 · Cited by 547 · cited 1×
“For a person with symptoms of dementia, APOE testing may offer additional supportthat any dementia may be due to AD, and thus potentially increase confidence to the clinical diagnosis [177].”
Memory improvement following induced hyperinsulinemia in Alzheimer’s disease
Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02002-0 · Cited by 538 · cited 1×
“Others suggested that the insulin response to an increase in glucose may be responsible for the effects on memo-308 ry [41,42].”
Strachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · cited 1×
“mance [145,278] and that the consumption of dietary”
Bennett, D. A., Schneider, J. A., Wilson, R. S., Bienias, J. L., & Arnold, S. E. (2004) · Archives of Neurology · doi:10.1001/archneur.61.3.378 · Cited by 526 · cited 1×
“A recent longitudinal clinicopathologic cohort study,using summary measures of amyloid load and NFTs, showed no correlation between amyloid load and clinical AD and global cognitive function, suggesting that the effect of amyloid deposition on clinical disease is mediated by NFTs [22].”
Baum, L., & Ng, A. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6403 · Cited by 483
Polyunsaturated Fatty Acids, Antioxidants, and Cognitive Function in Very Old Men
Kalmijn, S., Feskens, E. J. M., Launer, L. J., & Kromhout, D. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009029 · Cited by 453 · cited 1×
“Furthermore, a clear reduction of risk of cognitive decline has been found in a population sample with a high intake of polyunsaturated fatty acids (PU-FA) and monounsaturated fatty acids (MUFA) [140, 141,266,269–271].”
Is depression a risk factor for dementia or cognitive decline?
Jorm, A. F. (2000) · Gerontology · doi:10.1159/000022163 · Cited by 416
NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study
Elias, P. K., Elias, M. F., D'Agostino, R. B., Cupples, L. A., Wilson, P. W., Silbershatz, H., & Wolf, P. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1388 · Cited by 368 · cited 1×
“An alternative possibility is that, because age at onset and lenght of time of undetected diabetes differ greatly between these two types of diabetes, the incidence of repeated and untreated episodes of hypoglycaemia and potential cerebral disruption of glucose availability also differ [59].”
Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose
Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294
Becaria, A., Campbell, A., & Bondy, S. (2002) · Toxicology and Industrial Health · doi:10.1191/0748233702th157oa · Cited by 283 · cited 1×
“Particular attention has been focused on aluminium (Al) since excessive Al concentration has been shown both in bulk brain samples and in NFTs and SPs [19,24,63,110,179,181, 257], despite this toxic element having a low permeability of the blood-brainbarrier [24].”
Cigarette Smoking and Alcohol Consumption in Relation to Cognitive Performance in Middle Age
Kalmijn, S. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf135 · Cited by 281
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248 · cited 1×
“The promising preliminary results of propentofylline [187], a xanthine developed for this purpose, were not con-firmed in a subsequent large clinical trial, the Propento-fylline Plus Study [51].”
New Insights on How Metals Disrupt Amyloid β-Aggregation and Their Effects on Amyloid-β Cytotoxicity
Yoshiike, Y., Tanemura, K., Murayama, O., Akagi, T., Murayama, M., Sato, S., Sun, X., Tanaka, N., & Takashima, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010706200 · Cited by 244
Treatment of Alzheimer’s Disease with Clioquinol
Regland, B., Lehmann, W., Abedini, I., Blennow, K., Jonsson, M., Karlsson, I., Sjögren, M., Wallin, A., Xilinas, M., & Gottfries, C.-G. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051288 · Cited by 220 · cited 1×
“Moreover, a mild cognitive improvement has been reported for a small-scale open study of 30 AD patients following a 3 week treatment regime with another metal-complexingagent-clioquinol[236].”
Kaplan, R. J., Greenwood, C. E., Winocur, G., & Wolever, T. M. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.3.825 · Cited by 193 · cited 6×
“Current evidence suggests that poor glucose regulation is associated with poor cognitive performance [145,278] and that the consumption of dietary CHO can improve memory in certain situations [148, 183].”
InfluentialAlcohol Consumption and Cognitive Performance in the Framingham Heart Study
Elias, P. K., Elias, M. F., D'Agostino, R. B., Silbershatz, H., & Wolf, P. A. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010056 · Cited by 187 · cited 2×
“Several studies have assessed alcohol consumption and cognitive function among older adults [6,35,36, 56,60,61,89,118,142,153,155,156], but with inconsistent results.”
Effects of a 14-Day Healthy Longevity Lifestyle Program on Cognition and Brain Function
Small, G. W., Silverman, D. H. S., Siddarth, P., Ercoli, L. M., Miller, K. J., Lavretsky, H., Wright, B. C., Bookheimer, S. Y., Barrio, J. R., & Phelps, M. E. (2006) · The American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000219279.72210.ca · Cited by 176 · cited 1×
“Suggested shopping lists and menus guide subjects to follow a healthy diet plan, including five daily meals emphasizing antioxidant fruits and vegetables, n-3 PUFA, and low glycemic index carbohydrates [263].”
Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease
Molina, J. A., Jiménez-Jiménez, F. J., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González-Muñoz, M. J., de Bustos, F., Porta, J., Ortí-Pareja, M., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050071 · Cited by 167
Sex Differences in the Association between Alcohol Consumption and Cognitive Performance
Dufouil, C., Ducimeti re, P., Ducimeti re, P., Alp rovitch, A., & for the EVA Study Group (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009293 · Cited by 157 · cited 1×
“Several studies have assessed alcohol consumption and cognitive function among older adults [6,35,36, 56,60,61,89,118,142,153,155,156], but with inconsistent results.”
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141 · cited 1×
“In particular, preliminary findings on a novel bifunctional molecule-XH1 indicated this agent as a candidate metal chelator targeting Alzheimer’s amyloidogenesis and warrant further investigations [48].”
Hebert, L. E., Scherr, P. A., Beckett, L. A., Albert, M. S., Rosner, B., Talor, J. O., & Evans, D. A. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116749 · Cited by 128 · cited 1×
“Several studies have assessed alcohol consumption and cognitive function among older adults [6,35,36, 56,60,61,89,118,142,153,155,156], but with inconsistent results.”
Prospective Association of Smoking and Alcohol Use with Cognitive Function in an Elderly Cohort
EDELSTEIN, S. L., KRITZ-SILVERSTEIN, D., & BARRETT-CONNOR, E. (1998) · Journal of Women's Health · doi:10.1089/jwh.1998.7.1271 · Cited by 69
Cognitive Function after 11.5 Years of Alcohol Use: Relation to Alcohol Use
Leroi, I. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf107 · Cited by 69 · cited 2×
“Several studies have assessed alcohol consumption and cognitive function among older adults [6,35,36, 56,60,61,89,118,142,153,155,156], but with inconsistent results.”
Cited by
Chen, J.-H., Lin, K.-P., & Chen, Y.-C. (2009) · Journal of the Formosan Medical Association · doi:10.1016/s0929-6646(09)60402-2 · Cited by 288
Sharma, D. R., Wani, W. Y., Sunkaria, A., Kandimalla, R. J., Sharma, R. K., Verma, D., Bal, A., & Gill, K. D. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.055 · Cited by 144
Sumathi, T., Shobana, C., Thangarajeswari, M., & Usha, R. (2015) · Drug and Chemical Toxicology · doi:10.3109/01480545.2014.900068 · Cited by 56
Metadata
- Authors
- Solfrizzi, V., Colacicco, A. M., D'Introno, A., Capurso, C., Parigi, A. D., Capurso, S. A., Torres, F., Capurso, A., & Panza, F.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2006-11-14
- Volume
- 10
- Issue
- 2-3
- Pages
- 303-330
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W1453817828
- Cited by
- 60
- References
- 49
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.